As predicted, the results showed that the expression of Sox2 was upregulated with the decrease of tumor differentiation degree, whereas CK18 expression displayed the opposite trend, as revealed by immunohistochemistry (Supplementary Fig. S3A). The gene discussed is SOX2; the disease is neoplasm.